- USD/JPY holds onto recovery gains after declining heavily on Friday.
- US PMIs contradict Japan’s, cautious optimism prevails.
- RBA and the US data could offer intermediate moves while coronavirus updates keep the driver’s seat.
USD/JPY keeps it positive while taking rounds to 108.70 during the early Asian session on Tuesday. The yen pair recovered most of the Friday’s losses during its U-turn on Monday. While a halt in risk-off seems to play its role, upbeat performances of the US data, as compared to its Japanese counterparts, also helped the pair.
Risk recovery or a pause?
Although a lack of pessimism in China’s President Xi Jinping’s latest comments seems to have pushed markets towards risk-on, broad fears of coronavirus outbreak haven’t eloped. Also supporting the risk recovery could be the statement from the World Health Organization’s (WHO) Chief Dr. Tedros who again played down the need to cut travel/trade relations with China while fearing the epidemic. Even so, most global peers kept on curtailing their connections to Beijing, making it more difficult to count the contagion that has so far claimed 350+ lives globally.
In addition to the coronavirus fears, uncertainty surrounding Brexit also played its role to affect the investors’ decision.
While portraying the market’s risk sentiment, the US 10-year treasury yields remain mostly the same around 1.52% with Wall Street marking recovery. China’s markets witnessed heavy losses despite the government’s efforts to limit the short-selling, infuse liquidity.
The economic calendar flashed better signs…
As compared to the risk catalysts, economics flashed strong catalysts while looking for direction. The early-Monday release of Japan’s Jibun Bank Manufacturing PMI disappointed trades while the US Manufacturing PMIs from the ISM and the Markit managed to keep the US dollar on the recovery mode.
Looking forward, investors will keep eyes on the China/Brexit headlines as governments at those ends have upped efforts. This will also join the US Factory Orders (December), expected +1.1% versus -0.7% prior, for intermediate direction. It’s worth mentioning that the RBA interest rate decision will be the immediate catalyst even if the central bank isn’t expected to alter its current monetary policy.
While 200-day SMA, near 108.40 now, keeps the immediate downside limited, 100-day SMA and a two-week-old falling trend line, around 108.75 and 108.90 respectively, limit the pair’s short-term advances.
Additional important levels
|Today last price||108.68|
|Today Daily Change||0.33|
|Today Daily Change %||0.30%|
|Today daily open||108.35|
|Previous Daily High||109.14|
|Previous Daily Low||108.31|
|Previous Weekly High||109.28|
|Previous Weekly Low||108.31|
|Previous Monthly High||110.29|
|Previous Monthly Low||107.65|
|Daily Fibonacci 38.2%||108.63|
|Daily Fibonacci 61.8%||108.82|
|Daily Pivot Point S1||108.06|
|Daily Pivot Point S2||107.77|
|Daily Pivot Point S3||107.24|
|Daily Pivot Point R1||108.89|
|Daily Pivot Point R2||109.43|
|Daily Pivot Point R3||109.72|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.